Further, the endogenous binding relationship between SRPK2 and BRD4 in osteosarcoma cells was verified and the main binding site was analyzed in the CTD domain of BRD4 (Fig. 6F, G, Fig. S7). The gene discussed is BRD4; the disease is osteosarcoma.